Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Guo, Fei ^a,b   Parker Kerrigan, Brittany C ^a   Yang, Da ^a   Hu, Limei ^a   Shmulevich, Ilya ^c   Sood, Anil K ^a   Xue, Fengxia ^b   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Epithelial to mesenchymal transition (EMT); Long non coding RNA (lncRNA); Mesenchymal to epithelial transition (MET); microRNA (miRNA)

Indexed keywords

FIBRONECTIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 200; MICRORNA 506; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; UNTRANSLATED RNA;

CANCER STEM CELL; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUSION; HUMAN; MESENCHYMAL EPITHELIAL TRANSITION; METASTASIS; PROMOTER REGION; PROSTATE CANCER; REVIEW; ANIMAL; GENETICS; PHYSIOLOGY; RNA PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; EPIGENOMICS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84898030144     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-7-19     Document Type: Review

References (124)

1. Complex networks orchestrate epithelial-mesenchymal transitions. Thiery JP, Sleeman JP, Nat Rev Mol Cell Biol 2006 7 131 142 10.1038/nrm1835 16493418
2. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH, Cancer Res 2013 73 4147 4157 10.1158/0008-5472.CAN-12-4085 23687336
3. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Wu CY, Tsai YP, Wu MZ, Teng SC, Wu KJ, Trends Genet 2012 28 454 463 10.1016/j.tig.2012.05.005 22717049
4. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Lamouille S, Subramanyam D, Blelloch R, Derynck R, Curr Opin Cell Biol 2013 25 200 207 10.1016/j.ceb.2013.01.008 23434068
5. Cancer stem cells. Yu Z, Pestell TG, Lisanti MP, Pestell RG, Int J Biochem Cell Biol 2012 44 2144 2151 10.1016/j.biocel.2012.08.022 22981632
6. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. Mendez MG, Kojima S, Goldman RD, FASEB J 2010 2010 24
7. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W, Mol Cell Proteomics 2010 9 2405 2413 10.1074/mcp.M110.000240 20651304
8. Noncoding RNAs in cancer and cancer stem cells. Huang T, Alvarez A, Hu B, Cheng SY, Chin J Cancer 2013 32 582 593 10.5732/cjc.013.10170 24206916
9. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y, Oncol Rep 2014 31 358 364 24247585
10. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, Yu PF, Cheng XD, Int J Biol Sci 2013 9 587 597 10.7150/ijbs.6339 23847441
11. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F, Mol Biosyst 2012 8 2289 2294 10.1039/c2mb25070e 22722759
12. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J, Cancer Lett 2013 333 213 221 10.1016/j.canlet.2013.01.033 23354591
13. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY, Nature 2010 464 1071 1076 10.1038/nature08975 20393566
14. LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells. Hu P, Yang J, Hou Y, Zhang H, Zeng Z, Zhao L, Yu T, Tang X, Tu G, Cui X, Liu M, Cell Signal 2014 26 83 93 10.1016/j.cellsig.2013.10. 001 24113349
15. Targeting long non-coding RNAs in cancers: progress and prospects. Li CH, Chen Y, Int J Biochem Cell Biol 2013 45 1895 1910 10.1016/j.biocel.2013.05.030 23748105
16. Recent updates on the role of microRNAs in prostate cancer. Hassan O, Ahmad A, Sethi S, Sarkar FH, J Hematol Oncol 2012 5 9 10.1186/1756-8722-5-9 22417299
17. The clinical potential of microRNAs. Budhu A, Ji J, Wang XW, J Hematol Oncol 2010 3 37 10.1186/1756-8722-3-37 20925959
18. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D'Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D, Oncogene 2011 30 4231 4242 10.1038/onc.2011.140 21532615
19. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. Tan S, Li R, Ding K, Lobie PE, Zhu T, FEBS Lett 2011 585 2229 2234 10.1016/j.febslet.2011.05.042 21658389
20. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, Wu K, Nie Y, Fan D, Oncogene 2013 32 1363 1372 10.1038/onc.2012.156 22614005
21. ERalpha, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Guttilla IK, Adams BD, White BA, Trends Endocrinol Metab 2012 23 73 82 10.1016/j.tem.2011.12.001 22257677
22. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L, Wang H, Huang C, Sun S, PLoS One 2012 7 30771 10.1371/journal.pone.0030771 22363487
23. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J, Brabletz T, EMBO J 2011 30 770 782 10.1038/emboj.2010.349 21224848
24. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO, Mol Cell Biol 2009 29 5923 5940 10.1128/MCB.00332-09 19703993
25. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Gill BJ, Gibbons DL, Roudsari LC, Saik JE, Rizvi ZH, Roybal JD, Kurie JM, West JL, Cancer Res 2012 72 6013 6023 10.1158/0008-5472.CAN-12-0895 22952217
26. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-beta. Xu Q, Wang L, Li H, Han Q, Li J, Qu X, Huang S, Zhao RC, Int J Oncol 2012 41 959 968 22766682
27. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J, Am J Physiol Renal Physiol 2012 302 369 F379 10.1152/ajprenal.00268.2011 22012804
28. MIR-99a and MIR-99b modulate TGF-beta induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. Turcatel G, Rubin N, El-Hashash A, Warburton D, PLoS One 2012 7 31032 10.1371/journal.pone.0031032 22299047
29. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells. Su A, He S, Tian B, Hu W, Zhang Z, PLoS One 2013 8 71309 10.1371/journal.pone.0071309 23967190
30. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR192, a Smad3-dependent microRNA. Hong JP, Li XM, Li MX, Zheng FL, Int J Mol Med 2013 31 1436 1442 23588932
31. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, Kanthatidis P, Diabetes 2010 59 1794 1802 10.2337/db09-1736 20393144
32. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells. Zhang Z, Liu ZB, Ren WM, Ye XG, Zhang YY, Int J Mol Med 2012 30 856 862 22797360
33. Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells. Lei C, Wang Y, Huang Y, Yu H, Wu L, Huang L, PLoS One 2012 7 52310 10.1371/journal.pone.0052310 23284982
34. The role of the miR-200 family in epithelial-mesenchymal transition. Mongroo PS, Rustgi AK, Cancer Biol Ther 2010 10 219 222 10.4161/cbt.10.3.12548 20592490
35. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ, Nat Cell Biol 2008 10 593 601 10.1038/ncb1722 18376396
36. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T, EMBO Rep 2008 9 582 589 10.1038/embor.2008.74 18483486
37. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T, Nat Cell Biol 2009 11 1487 1495 10.1038/ncb1998 19935649
38. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ, Cancer Res 2008 68 7846 7854 10.1158/0008-5472.CAN-08-1942 18829540
39. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. Mizuguchi Y, Specht S, Lunz JG 3rd, Isse K, Corbitt N, Takizawa T, Demetris AJ, PLoS One 2012 7 32449 10.1371/journal.pone.0032449 22384255
40. Smad3 regulates E-cadherin via miRNA-200 pathway. Ahn SM, Cha JY, Kim J, Kim D, Trang HT, Kim YM, Cho YH, Park D, Hong S, Oncogene 2012 31 3051 3059 10.1038/onc.2011.484 22020340
41. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC, Nat Cell Biol 2011 13 317 323 10.1038/ncb2173 21336307
42. p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression. Schubert J, Brabletz T, Cell Res 2011 21 705 707 10.1038/cr.2011.62 21483453
43. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J, Rodova M, Nanta R, Meeker D, van Veldhuizen PJ, Srivastava RK, Shankar S, Neuro Oncol 2013 15 691 706 10.1093/neuonc/not011 23482671
44. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Guo L, Chen C, Shi M, Wang F, Chen X, Diao D, Hu M, Yu M, Qian L, Guo N, Oncogene 2013 32 5272 5282 10.1038/onc.2012.573 23318420
45. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH, Stem Cells 2009 27 1712 1721 10.1002/stem.101 19544444
46. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH, Cancer Lett 2011 307 26 36 10.1016/j.canlet.2011.03.012 21463919
47. DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer. Sureban SM, May R, Qu D, Weygant N, Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG, Houchen CW, PLoS One 2013 8 73940 10.1371/journal.pone.0073940 24040120
48. Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT). Grassian AR, Lin F, Barrett R, Liu Y, Jiang W, Korpal M, Astley H, Gitterman D, Henley T, Howes R, Levell J, Korn JM, Pagliarini R, J Biol Chem 2012 287 42180 42194 10.1074/jbc.M112.417832 23038259
49. A MicroRNA targeting dicer for metastasis control. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Daidone MG, Bicciato S, Piccolo S, Cell 2010 141 1195 1207 10.1016/j.cell.2010.05.017 20603000
50. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X, Wan XP, Med Oncol 2013 30 484 23392577
51. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. Parker BC, Zhang W, Chin J Cancer 2013 32 594 603 10.5732/cjc.013.10178 24206917
52. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, Zielenska M, Squire JA, Neoplasia 2006 8 465 469 10.1593/neo.06283 16820092
53. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R, PLoS One 2011 6 21650 10.1371/journal.pone.0021650 21747944
54. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A, Gut 2013 62 1315 1326 10.1136/gutjnl-2011-301846 22735571
55. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. Neves R, Scheel C, Weinhold S, Honisch E, Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S, Uhrberg M, BMC Res Notes 2010 3 219 10.1186/1756-0500-3-219 20682048
56. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS, Borre M, Peter ME, Orntoft TF, Kjems J, Clark SJ, Int J Cancer 2011 128 1327 1334 10.1002/ijc.25461 20473948
57. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW, PLoS One 2010 5 8697 10.1371/journal.pone.0008697 20084174
58. Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, Yang C, Toxicol Sci 2011 121 110 122 10.1093/toxsci/kfr029 21292642
59. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N, Oncogene 2013 32 3286 3295 10.1038/onc.2012.334 22847613
60. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H, Cancer Sci 2013 104 48 54 10.1111/cas.12030 23013135
61. miR-655 Is an EMT-suppressive MicroRNA targeting ZEB1 and TGFBR2. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, Inazawa J, Kozaki k, PLoS One 2013 8 62757 10.1371/journal.pone.0062757 23690952
62. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G, Oncogene 2013 doi: 10.1038/onc.2013.53. [Epub ahead of print]
63. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, Muller PA, Dotsch V, Kehrloesser S, Sayan BS, Giaccone G, Lowe SW, Takahashi N, Vandenabeele P, Knight RA, Levine AJ, Melino G, Proc Natl Acad Sci U S A 2012 109 15312 15317 10.1073/pnas.1110977109 22949650
64. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z, Carcinogenesis 2013 34 539 549 10.1093/carcin/bgs374 23188671
65. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI, J Cell Biol 2011 195 417 433 10.1083/jcb.201103097 22024162
66. MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity/EMT governed by p53. Brabletz T, Cell Cycle 2012 11 215 216 10.4161/cc.11.2.18900 22214667
67. MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling. Cha YH, Kim NH, Park C, Lee I, Kim HS, Yook JI, Cell Cycle 2012 11 1273 1281 10.4161/cc.19618 22421157
68. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. Moes M, le Bechec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E, PLoS One 2012 7 35440 10.1371/journal.pone.0035440 22514743
69. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. Qu Y, Li WC, Hellem MR, Rostad K, Popa M, McCormack E, Oyan AM, Kalland KH, Ke XS, Int J Cancer 2013 133 544 555 10.1002/ijc.28056 23354685
70. Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. Ding X, Park SI, McCauley LK, Wang CY, J Biol Chem 2013 288 10241 10253 10.1074/jbc.M112.443655 23447531
71. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K, Oncogene 2013 32 296 306 10.1038/onc.2012.58 22370643
72. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynold S, Cheng H, Rupaimoole R, Cogdell D, Nykter M, Broaddus R, Rodriguez-Aguayo C, Lopez-Berestein G, Liu J, Shmulevich I, Sood AK, Chen K, Zhang W, Cancer Cell 2013 23 186 199 10.1016/j.ccr.2012.12.020 23410973
73. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H, Int J Cancer 2012 130 2044 2053 10.1002/ijc.26218 21633953
74. miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB, Mol Cancer Ther 2012 11 1166 1173 10.1158/1535-7163.MCT-12- 0100 22402125
75. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Chang CJ, Hsu CC, Chang CH, Tsai LL, Chang YC, Lu SW, Yu CH, Huang HS, Wang JJ, Tsai CH, Chou MY, Yu CC, Hu FW, Oncol Rep 2011 26 1003 1010 21725603
76. Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. Li B, Han Q, Zhu Y, Yu Y, Wang J, Jiang X, FEBS J 2012 279 2393 2398 22540680
77. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Nairismagi ML, Vislovukh A, Meng Q, Kratassiouk G, Beldiman C, Petretich M, Groisman R, Fuchtbauer EM, Harel-Bellan A, Groisman I, Oncogene 2012 31 4960 4966 10.1038/onc.2011.650 22266852
78. miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma. Hernandez JM, Elahi A, Clark CW, Wang J, Humphries LA, Centeno B, Bloom G, Fuchs BC, Yeatman T, Shibata D, Ann Surg Oncol 2013 Suppl 3 625 635
79. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. Yang F, Sun L, Li Q, Han X, Lei L, Zhang H, Shang Y, EMBO J 2012 31 110 123 10.1038/emboj.2011.364 21983900
80. An miR-502-binding site single-nucleotide polymorphism in the 3′-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K, Clin Cancer Res 2009 15 6292 6300 10.1158/1078-0432.CCR-09-0826 19789321
81. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA, Nat Cell Biol 2010 12 247 256 20173740
82. MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L, Gemma A, Int J Oncol 2012 41 869 875 22752005
83. Myc-modulated miR-9 makes more metastases. Khew-Goodall Y, Goodall GJ, Nat Cell Biol 2010 12 209 211 20173743
84. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Lu MH, Huang CC, Pan MR, Chen HH, Hung WC, Clin Cancer Res 2012 18 6416 6425 10.1158/1078-0432.CCR-12-0832 23045246
85. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC, Mol Oncol 2013 7 884 894 10.1016/j.molonc.2013.04.007 23684102
86. miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. Arora H, Qureshi R, Park WY, PLoS One 2013 8 64273 10.1371/journal.pone. 0064273 23717581
87. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY, Breast Cancer Res Treat 2012 134 1081 1093 10.1007/s10549-012-2034-4 22476851
88. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, Lu WY, Xuan JW, Deng Z, Yang BB, J Cell Sci 2013 126 1517 1530 10.1242/jcs.122895 23418359
89. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J, Carcinogenesis 2010 31 766 776 10.1093/carcin/bgp250 19843643
90. Tumor suppressive microRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H, Int J Oncol 2012 41 805 817 22766839
91. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A, Dai Y, Zhao X, Biochem J 2011 440 23 31 10.1042/BJ20111006 21770894
92. MiRNA-200b represses transforming growth factor-beta1-induced EMT and fibronectin expression in kidney proximal tubular cells. Tang O, Chen XM, Shen S, Hahn M, Pollock CA, Am J Physiol Renal Physiol 2013 304 1266 1273 10.1152/ajprenal.00302.2012 23408168
93. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW, Zhang Y, Xuan JW, Yee SP, Siragam V, Yang BB, Nat Cell Biol 2009 11 1031 1038 10.1038/ncb1917 19633662
94. Clinical implications of microRNAs in liver cancer stem cells. Chai S, Ma S, Chin J Cancer 2013 32 419 426 10.5732/cjc.013.10038 23668930
95. Silencing of microRNAs in vivo with 'antagomirs'. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M, Nature 2005 438 685 689 10.1038/nature04303 16258535
96. MicroRNA therapeutics: principles, expectations, and challenges. Rupaimoole R, Han HD, Lopez-Berestein G, Sood AK, Chin J Cancer 2011 30 368 370 10.5732/cjc.011.10186 21627858
97. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family. Song F, Yang D, Liu B, Guo Y, Zheng H, Li L, Wang T, Yu J, Zhao Y, Niu R, Liang H, Winkler H, Zhang W, Hao X, Chen K, Clin Cancer Res 2013 20 878 889 24352645
98. Tumour angiogenesis regulation by the miR-200 family. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, et al. Nat Commun 2013 4 2427 24018975
99. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-beta and miR-24: role in epithelial-to-mesenchymal transition. Papadimitriou E, Vasilaki E, Vorvis C, Iliopoulos D, Moustakas A, Kardassis D, Stournaras C, Oncogene 2012 31 2862 2875 10.1038/onc.2011.457 21986943
100. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. Gebeshuber CA, Zatloukal K, Martinez J, EMBO Rep 2009 10 400 405 10.1038/embor.2009.9 19247375
101. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL, Oncogene 2012 31 5162 5171 10.1038/onc.2012.11 22286770
102. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spokerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D, Sci Signal 2011 4 a41 10.1126/scisignal.4159ec41 21673316
103. MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis. Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M, J Clin Invest 2013 123 566 579 23321667
104. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Ward A, Balwierz A, Zhang JD, Kublbeck M, Pawitan Y, Hielscher T, Wiemann S, Sahin O, Oncogene 2013 32 1173 1182 10.1038/onc.2012.128 22508479
105. Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, Wang WJ, Chen Q, Tang F, Liu XP, Xu ZD, Cell Death Differ 2011 18 16 25 10.1038/cdd.2010.103 20798686
106. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Vetter G, Saumet A, Moes M, Vallar L, le Bechec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E, Oncogene 2010 29 4436 4448 10.1038/onc.2010.181 20543867
107. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Zhang Z, Liu S, Shi R, Zhao G, Cancer Genet 2011 204 486 491 10.1016/j.cancergen.2011.07.004 22018270
108. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. Hamada S, Satoh K, Miura S, Hirota M, Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, Motoi F, Unno M, Shimosegawa T, J Cell Physiol 2013 228 1255 1263 10.1002/jcp.24280 23139153
109. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J, Cancer Lett 2013 337 226 236 10.1016/j.canlet.2013.05.007 23684551
110. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N, Mol Cancer 2011 10 99 10.1186/1476-4598-10-99 21851624
111. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). Zhang LY, Liu M, Li X, Tang H, J Biol Chem 2013 288 4035 4047 10.1074/jbc.M112.410506 23212913
112. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang X, Liu Q, Zhang J, Liver Int 2013 33 1271 1280 10.1111/liv.12190 23725476
113. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC, Qin LX, Wang L, Zhou J, Ren ZG, Li YX, Fan J, Wu WZ, J Exp Med 2013 210 789 803 10.1084/jem.20120153 23478189
114. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma. Cui SY, Huang JY, Chen YT, Song HZ, Feng B, Huang GC, Wang R, Chen LB, De W, Mol Cancer Res 2013 11 699 713 10.1158/1541-7786.MCR-13-0019-T 23562878
115. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Xia H, Ooi LL, Hui KM, Hepatology 2013 58 629 641 10.1002/hep.26369 23471579
116. MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Qi J, Rice SJ, Salzberg AC, Runkle EA, Liao J, Zander DS, Mu D, Cell Cycle 2012 11 177 186 10.4161/cc.11.1.18576 22185756
117. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, Diederichs S, Eichmuller SB, J Invest Dermatol 2013 133 768 775 10.1038/jid.2012.357 23151846
118. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, Yu W, FEBS Lett 2012 586 3761 3765 10.1016/j.febslet.2012.09.016 23010597
119. miR-149 inhibits Non-small-cell lung cancer cells EMT by targeting FOXM1. Ke Y, Zhao W, Xiong J, Cao R, Biochem Res Int 2013 2013 506731 23762558
120. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH, Oncogene 2012 31 764 775 10.1038/onc.2011.269 21725366
121. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T, Mol Cancer Res 2012 10 3 10 10.1158/1541-7786.MCR-11-0272 22064652
122. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W, PLoS One 2011 6 17745 10.1371/journal.pone.0017745 21445232
123. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Ocana OH, Corcoles R, Fabra A,
124. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J, Cancer Cell 2012 22 725 736 10.1016/j.ccr.2012.09.022 23201165